Peroxisome proliferator-activated receptors ligands and ischemia-reperfusion injury

被引：0
|
作者：
Rosanna Di Paola
Salvatore Cuzzocrea
机构：
[1] University of Messina,Department of Clinical and Experimental Medicine and Pharmacology, School of Medicine
[2] Torre Biologica-Policlinico Universitario,undefined
[3] IRCCS Centro Neurolesi Bonino-Pulejo,undefined
来源：
Naunyn-Schmiedeberg's Archives of Pharmacology | 2007年 / 375卷
关键词：
Peroxisome proliferator-activated receptors; Ischemia; Reperfusion tissue injury;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Peroxisome proliferator-activated receptors (PPARs) belong to a subfamily of transcription nuclear factors. Three isoforms of PPARs have been identified: α, β/δ and γ, encoded by different genes and distributed in various tissues. They play important roles in metabolic processes like regulation of glucose and lipid redistribution. They also have anti-atherogenic, anti-inflammatory as well as antihypertensive functions. There is good evidence that ligands of PPARs reduce tissue injury associated with ischemia and reperfusion. The potential utility of PPAR ligands in ischemia and reperfusion will be discussed in this review.
引用
收藏
页码：157 / 175
页数：18
相关论文
共 50 条
  • [31] Peroxisome proliferator-activated receptors.
    Ziouzenkova O.
    Perrey S.
    Marx N.
    Bacqueville D.
    Plutzky J.
    Current Atherosclerosis Reports, 2002, 4 (1) : 59 - 64
  • [32] Peroxisome Proliferator-Activated Receptors and Atherosclerosis
    Soskic, Sanja S.
    Dobutovic, Branislava D.
    Sudar, Emina M.
    Obradovic, Milan M.
    Nikolic, Dragana M.
    Zaric, Bozidarka L.
    Stojanovic, Srdan D.
    Stokic, Edita J.
    Mikhailidis, Dimitri P.
    Isenovic, Esma R.
    ANGIOLOGY, 2011, 62 (07) : 523 - 534
  • [33] Peroxisome proliferator-activated receptors and angiogenesis
    Biscetti, F.
    Straface, G.
    Pitocco, D.
    Zaccardi, F.
    Ghirlanda, G.
    Flex, A.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2009, 19 (11) : 751 - 759
  • [34] Signalling by peroxisome proliferator-activated receptors
    Wahli, W
    Krey, G
    Devchand, P
    Keller, H
    Ijpenberg, A
    Jeannin, E
    Braissant, O
    Desvergne, A
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 : U79 - U79
  • [35] Regulation of peroxisome proliferator-activated receptors
    Sorensen, HN
    Treuter, E
    Gustafsson, JA
    VITAMINS AND HORMONES - ADVANCES IN RESEARCH AND APPLICATIONS, VOL 54, 1998, 54 : 121 - 166
  • [36] Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications - a review
    Grygiel-Gorniak, Bogna
    NUTRITION JOURNAL, 2014, 13
  • [37] Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications - a review
    Bogna Grygiel-Górniak
    Nutrition Journal, 13
  • [38] Evaluation of synthetic sphingolipid analogs as ligands for peroxisome proliferator-activated receptors
    Tsuji, Kiyomi
    Satoh, Shigeru
    Mitsutake, Susumu
    Murakami, Itsuo
    Murakami, Itsuo
    Park, Jeong-Ju
    Li, Qian
    Chang, Young-Tae
    Chung, Sung-Kee
    Igarashi, Yasuyuki
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (06) : 1643 - 1646
  • [39] Proinflammatory cytokine and ligands modulate cardiac peroxisome proliferator-activated receptors
    Lee, T-I.
    Kao, Y-H.
    Chen, Y-C.
    Chen, Y-J.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2009, 39 (01) : 23 - 30
  • [40] The role of various peroxisome proliferator-activated receptors and their ligands in clinical practice
    Derosa, Giuseppe
    Sahebkar, Amirhossein
    Maffioli, Pamela
    JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (01) : 153 - 161
12345